FDA Grants Accelerated Approval to Zenocutuzumab-zbco for Non-Small Cell Lung Cancer and Pancreatic Adenocarcinoma By Ogkologos - January 10, 2025 104 0 Facebook Twitter Google+ Pinterest WhatsApp Evidence for efficacy is based on the results from the eNRGy study Source RELATED ARTICLESMORE FROM AUTHOR EMA Recommends Extension of Therapeutic Indications for Nivolumab and Ipilimumab to Unresectable or Advanced HCC ESMO Sarcoma and Rare Cancers Congress 2025, Lugano, Switzerland, 20-22 March New on NCI’s Websites for March 2025 MOST POPULAR Efficacy of a Bispecific Monoclonal Antibody Glofitamab for Relapsed or Refractory... December 19, 2022 New Imaging Tool Could Predict Whether Hormone Therapy Will Work in... February 4, 2021 Lung-Sparing Surgery Is Effective for Some with Early-Stage Lung Cancer March 9, 2023 PSMA PET-CT Accurately Detects Prostate Cancer Spread, Trial Shows May 11, 2020 Load more HOT NEWS Working Together to Choose a Cancer Treatment Plan: A Caregiver’s Perspective Jonas Brothers Visit Fan In Hospital Who Missed Their Concert Due... Talking About Sexual Health Concerns With Your Cancer Care Team: How... Study Shows Experimental Screening Test Can Detect Endometrial and Ovarian Cancers
